Hepatocellular carcinoma (HCC) was thought historically to arise from hepatocytes, but gene expression studies have suggested it can also arise from fetal progenitor cells or their adult progenitor progeny. Here we report the identification of a unique population of fetal liver progenitor cells in mice that can serve as a cell of origin in HCC development. on January 13, 2018.
PI3K/mTOR and Sonic Hedgehog pathways (3). Gene mutations that activate the
Wnt/ȕ-catenin signaling pathway are observed in 50% of HCCs, and the most common of these is CTNNB1 mutations that result in stabilization of ȕ-catenin (4). Thus, one approach for generating mouse models for HCC has been to activate the Wnt signaling pathway via Ctnnb1 mutation (5) . Wnt pathway activation in adult murine hepatocytes fails to induce tumors (6) (7) (8) . However, introduction of genetic alterations such as Ha-Ras or Akt mutation in adult hepatocytes in addition to Wnt pathway activation does result in HCC (9, 10) . Published data therefore indicate that activation of the Wnt pathway alone is insufficient for HCC initiation, at least in hepatocytes.
Because the Wnt signaling pathway plays a critical role in regulating stem/progenitor cell self-renewal and because of the suggestion that a fetal progenitor is the cell of origin for some human HCCs, we hypothesized that activation of the Wnt pathway in a unique population of bipotential fetal liver cells that we have identified could give rise to HCC in vivo without the introduction of additional genetic events. As presented below, these fetal liver cells are characterized by their expression of the Cited1-CreER TM -GFP BAC transgene (11) and express CD45, in addition to markers characteristic of hepatic
Research. Cell culture. GFP-sorted cells from fetal liver were cultured in laminin-coated dishes for 21 days in differentiating medium (16) . Cells were photomicrographed, RNA was extracted, cDNA was synthesized and semi-quantitative PCR analysis was performed as previously described (17) .
X-gal staining. Cited1-CreER TM -GFP; ROSA26R-LacZ embryos were treated in utero at E14.5 with tamoxifen (3mg/40g maternal body weight). Livers were dissected at two months of age and stained with X-gal as described in Supplemental Methods.
Statistical analysis. Statistical significance of the results between groups was
determined by Student's t-test. Statistical differences were considered significant if p <0.05 (*), <0.01 (**) and <0.001 (***). All data is represented as mean + SEM.
Research. positive for ȕ-galactosidase enzyme activity (Fig. 1A, a-c ). Immunofluorescence analysis with antibody specific for ȕ-galactosidase on liver sections showed ȕ-gal + cells in the liver (Fig. 1A, d ). Co-staining with Sox9, a marker for adult liver progenitors (19) and ȕ-galactosidase antibodies identified cells of bile ducts that were double positive, suggesting that the transgene-expressing cells give rise to the ductal cells (Fig. 1A , e). EpCAM expression was detected in 87% of GFP + cells in E11.5 livers (Fig. 1B, a) . This decreased to 49% and 35% at E12.5 and 13.5, respectively (Fig. 1B, b) . Of note, all cells positive for EpCAM were also positive for DLK1 (Fig. 1B, a) . littermates served as controls.
Expression of cell surface markers characteristic of progenitors in the CreER
Experimental animals displayed no reduced viability, but did display hepatomegaly (Table 2) . Palpatable tumors were detected as early as eight weeks and, by 26 weeks,
developed tumors ( Fig. 2A ). Mice were sacrificed when they became moribund and tumors were collected. Within an animal, multiple tumors of variable sizes were randomly distributed in all liver lobes (Fig. 2B, b ). Of note, apparent lung metastases were also grossly observed in two of the 20 tumor-bearing mice that were sacrificed at 6 months of age (arrowheads, Fig. 2B , c). Genotypic analysis confirmed the presence of the recombined Ctnnb1 allele in the tumors (Fig. 2B, d ). Interestingly, loss of the wildtype allele of Ctnnb1 (marked by *) was noted in some tumors (e.g., T2).
Complete histological evaluation was carried out on liver sections from 12 tumorbearing and control mice. Small foci of aberrant hepatocytes with increased basophilic staining was observed in most sections (Fig. 2C, b ) when compared to normal liver sections (Fig. 2C, a) . Nodular adenomatous lesions (Fig. 2C, c ) and HCCs were most commonly present (Fig. 2C, d-f ). HCCs were characterized by cytological atypia, occasional mitotic figures (Fig. 2C, g ) and peliosis (arrows, Fig. 2C , d) and were very similar to human HCC.
Unexpectedly, of the 12 HCC-bearing mice, five (42%) also had histologically detectable hepatoblastomas (HBs). HBs were typically composed of undifferentiated monotypic cells, characteristic of embryonic liver cells, with scanty cytoplasm (Fig. 2C , e) and numerous mitotic figures (Fig. 2C, h ). In human tumors this histology is classified as the embryonal undifferentiated subtype of HB (22) . Some mice also had moderately differentiated pure fetal HB with steatosis (Table S1 & Fig. 2C , f). These observations are consistent with the fact that we targeted a progenitor population.
Histological evaluation of a lung metastasis revealed cells with increased basophilic staining, steatosis and relatively uniform nuclei (Fig. 2C, i 3B ).
ȕ-catenin IHC demonstrated heterogeneous expression with increased cytoplasmic and nuclear localization in HCCs, pure fetal HBs, and lung metastasis from
Tg-ȕ-cat S mice (Fig. 3C, a,b,d ). In contrast, ȕ-catenin staining in the embryonal undifferentiated HB was strikingly nuclear (Fig. 3C, c) . In livers from littermate control mice, Wnt signaling activity, marked by the expression of GS, was restricted to a single layer of perivenular hepatocytes (Fig. S3A, b) . GS immunohistochemistry revealed both an increased and an altered expression pattern in all Tg-ȕ-cat S HCCs in which it was uniformly expressed in all the hepatocytes of the tumor and was not restricted only to perivenular hepatocytes (Fig. 3C, e) . In contrast, GS expression was heterogeneous in the pure fetal HB and lung metatasis (Fig. 3C, f,h ). In the embryonal undifferentiated variant of HB, GS immunoreactivity was hardly detectable (Fig. 3C, g ). In one month old
Tg-ȕ-cat S mice that did not show any overt tumors, we detected increased cytoplasmic and nuclear localization of ȕ-catenin, aberrant spatial expression of GS in nonperivenular areas and increased proliferation as detected by Ki67 (Fig. S3B, d -f) when compared with age-matched controls (Fig. S3B, a-c (Fig. S3C) . Canonical Wnt targets were also upregulated in these mice (Fig. S3D) .
Tumors from Tg-ȕ-cat S mice (Fig. 3C, i-k) and the lung metastasis (Fig. 3C, l) showed increased proliferation (Ki67 staining) compared to liver sections from littermate control mice (Fig. S3B, c) . The embryonal undifferentiated variant of HB displayed the highest frequency of proliferating cells (Fig. 3C, k) . (Fig. 4A ). In the PI3K/mTOR pathway, besides upregulation of mTOR (total and pS2448) by Western analysis, we also identified upregulation of Raptor and GȕL, two TORC1 complex proteins. Interestingly, PTEN, the negative upstream regulator of the mTOR pathway whose loss results in HCC (26) , was significantly downregulated in Tg-ȕ-cat S tumors (Fig. 4B ). Besides these two key
Research. 
signaling pathways, upregulation of stathmin, SRC, and CHK1, all of which have been associated with hepatocarcinogenesis (27) (28) (29) , was detected by RPPA analysis (Fig.   S4 ). Immunohistochemistry with PKCĮ (pT492) and ERK1/2 (pT202) antibodies confirmed their expression in HCC tissue (Fig. 4C, e,f) . Similarly, upregulation of mTOR (pS2448) and S6 kinase (pS235/236) was detected in the HCC lesions (Fig. 4C, g,h) .
While the HB fetal variant showed upregulation of PKCĮ (pT492), ERK1/2 (pT202), mTOR (p2448) and S6 kinase (pS235/236) (Fig. 4C, m-p) , the embryonal undifferentiated variant showed only upregulation of PKCĮ (pT492) and only a few phospho-S6 positive cells were detected (Fig. 4C, i, l) , suggesting that alterations in signaling pathways were specific to the cell type comprising the tumor.
Tumors express stem/progenitor markers. To test if the HCCs in our model
expressed stem/progenitor markers characteristic of the cells from which they arose, we performed Q-RT PCR. A statistically significant increase in the expression of Cited1, Dlk1, CD133, and Lgr5 was observed (Fig. 5A ). In addition, the expression of Afp, a marker for premature hepatocytes and also a Wnt target gene in liver, and Sox9 and Sox4, markers for adult progenitors in liver, were also significantly increased in tumors (Fig. 5A ). Increased Cited1, Lgr5, Sox9 and Afp was also confirmed at the protein level by Western blotting (Fig. 5B) . By IHC, CITED1 expression was detected uniformly in all hepatocytes of the HCCs (Fig. 5C, a) , whereas DLK1 expression was more heterogeneous (Fig. 5C, b ) and SOX9 expression was nuclear and confined to small cells in tumors (arrows, Fig. 5C, c) . In the embryonal undifferentiated variant of HB, CITED1 expression was weak, whereas DLK1 and SOX9 expression was robust with almost all cells expressing these markers (Fig. 5C, d,e,f) . In the pure fetal HB, CITED1
Research.
on January 13, 2018. © 2014 American Association for Cancer cancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. expression was uniform and robust (Fig. 5C, g ), high DLK1 expression was restricted to a few hepatocyte cells, (Fig. 5C, h ), and SOX9 expression was nuclear and restricted to a very few cells as in the HCCs (arrows, Fig. 5C, i) . CITED1 expression was seen in bile ducts (black arrows, Fig. 5D, a) and hepatocytes emerging from them (red arrows, Fig.   5D , a) and in tumors (HCCs and HBs) around bile ducts (Fig. 5D, b,c) .
Discussion
We report here the identification of a novel population of fetal liver progenitor cells and the development of endogenous and metastatic liver tumors when ȕ-catenin stabilization/Wnt pathway activation --alone --is targeted to these cells. These tumors also showed upregulation of the Ras/Raf/MEK/MAPK and PI3K/mTOR pathways.
Wnt pathway activation by CTNNB1 mutation is observed in 20-40% of human HCCs and 50-90% of HB (30) (31) (32) . However, in mice activation of the Wnt pathway by over-expression of wild type or stable mutants of ȕ-catenin in hepatocytes failed to result in tumor development (6, 7, 33) . For tumors to develop in these mice, Wnt pathway activation had to be accompanied by additional alterations such as activation of either Ha-Ras or Akt (9, 10) or treatment with hepatotoxins (34) . In this study, we hypothesized that ȕ-catenin stabilization in an early fetal progenitor would be sufficient for tumor development. Therefore, using the Cited1-CreER TM -GFP mouse strain (11) 
Like human HCCs, the Tg-ȕ-cat S tumors histologically showed nuclear atypia, mitotic figures, and peliosis, and robustly and heterogeneously expressed GS and nuclear ȕ-catenin. Approximately ~40% of mice that developed HCCs also developed
HBs. In the Tg-ȕ-cat S mice, ȕ-catenin was stabilized at ~E14.5, at which time hepatoblast lineage bifurcation begins. Because of this, it is possible that ȕ-catenin stabilization occurred in a heterogeneous population of fetal progenitors, some of which were more differentiated than others. This is fully consistent with the occurrence of both HCC and HB in these mice. Like human HBs that are classified into distinct classes based on their histology (22), we observed two distinct histologies: a pure fetal moderately differentiated HB and an embryonal undifferentiated HB. Some mutant mice showed both histologies of HB. Like human HBs, both types of murine HBs displayed increased nuclear ȕ-catenin expression, homogeneously in the embryonal HBs and heterogeneously in the fetal histology HBs. GS expression in the fetal moderately differentiated HBs was similar to that in the HCCs, although more heterogeneous. GS expression was lower in the embryonal undifferentiated HBs, consistent with the expression of GS in more differentiated cells of the liver.
Lung metastases were grossly observable in some Tg-ȕ-cat S mice, an unusual occurrence in mouse models. 46% and 44% of human HCC and HB patients, respectively, have metastatic disease, primarily in the lung (38, 39) . As was the case for the primary Tg-ȕ-cat S tumors, we observed robust ȕ-catenin expression in a lung metastasis.
The observation of HCCs and sometimes, additionally, HBs, raises a question about the cell type(s) from which these tumors arose. HBs are thought to arise from
Research. Activating mutations of the Wnt signaling pathway are very common in both mouse and human HCC (30) , and in human tumors Wnt target genes, both canonical and liver-specific targets, are upregulated (23, 24, 44, 45) . We observed increased cytoplasmic and nuclear localization of ȕ-catenin in the liver of young (one month old) hepatocytes, nor did these mice develop tumors (7) . These differences between the two models suggest that the ability of Wnt pathway activation to result in HCCs critically depends on the activation of canonical Wnt targets.
Tg-ȕ-cat
S tumors also expressed FGFR1, commonly observed in human HCCs, and displayed activation of the Ras/Raf/MAPK and the PI3K/AKT/mTOR pathways, both of which can be activated by FGFR1 and are present in human HCCs characterized by aggressive behavior (46) . Specifically, PKCĮ, which has been reported to contribute to HCC proliferation, migration, and invasion via activation of MAPK (47, 48) , was upregulated in Tg-ȕ-cat S tumors as was pMEK1/2 and pERK1/2. Phospho-FOXO3A, a proapoptotic protein which is negatively regulated via phosphorylation by pERK1/2, was increased. PTEN was downregulated in tumors, whereas components of the TORC1 complex, p-mTOR, RAPTOR, and GȕL, were upregulated, consistent with the known role of PTEN in negatively regulating the mTOR pathway. As noted previously, tumors displayed an increase in both liver-specific and canonical ȕ-catenin targets. One, c-MYC, is also an effector of the MEK/ERK pathway, and another, GS, has been reported to enhance tumor growth by activation of the mTOR pathway (49, 50) . Thus the activation of the Wnt pathway engineered into the CreER TM -GFP + fetal liver progenitors may have not only initiated tumorigenesis, but may have also enhanced the effect of mTOR and MEK/ERK pathway activation. We also observed up-regulation of Stathmin, SRC, and CHK1, which have also been implicated in hepatocarcinogenesis (27) (28) (29) .
By RPPA analysis, Tg-ȕ-cat S HCCs uniformly displayed activation of the mTOR and MEK/ERK pathways and this was subsequently verified by IHC. In contrast to
HCCs, we observed distinct patterns of protein/phospho-protein expression in the two This model will be extremely valuable for understanding the pathobiology of human HCCs, in particular those that display an especially poor prognosis and are thought to be of stem/progenitor origin.
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